This inventor holds 1 USPTO granted patent. Top assignees: Institute for Cancer Research, The University of Akron. Active years: 2021.
Company Filing History:
1 out of 69 
1 out of 665 
Years Active: 2021
Title: Michael Lee Stromyer: Innovator in Bladder Cancer Treatment
Introduction
Michael Lee Stromyer is a notable inventor based in Allison Park, Pennsylvania. He has made significant contributions to the field of cancer treatment, particularly focusing on bladder cancer. His innovative work has led to the development of pharmaceutical compounds that aim to improve patient outcomes.
Latest Patents
Stromyer holds a patent for "Azolium salts for treatment of non-muscle invasive bladder cancer." This invention provides pharmaceutical compounds specifically designed for the treatment of high-grade superficial bladder cancer in patients who require such intervention. The patent details compositions of azolium salts that are utilized in this treatment, showcasing Stromyer's commitment to advancing medical science.
Career Highlights
Throughout his career, Stromyer has worked with esteemed organizations such as the Institute for Cancer Research and The University of Akron. His experience in these institutions has allowed him to collaborate with other professionals and contribute to groundbreaking research in cancer treatment.
Collaborations
Stromyer has collaborated with notable colleagues, including David Joseph Weader and Uttam Satyal. These partnerships have further enriched his research and development efforts in the field of oncology.
Conclusion
Michael Lee Stromyer's contributions to the treatment of bladder cancer through his innovative patent demonstrate his dedication to improving healthcare. His work continues to inspire advancements in cancer research and treatment methodologies.